BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7687150)

  • 1. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism.
    Narayan M; Srinath S; Anderson GM; Meundi DB
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):630-5. PubMed ID: 7687150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
    Arch Gen Psychiatry; 1977 May; 34(5):545-50. PubMed ID: 860891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of secretin for the treatment of autism].
    Toda Y; Mori K; Hashimoto T; Miyazaki M; Kuroda Y
    No To Hattatsu; 2004 Jul; 36(4):289-95. PubMed ID: 15272612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of secretin for autism alters dopamine metabolism in the central nervous system.
    Toda Y; Mori K; Hashimoto T; Miyazaki M; Nozaki S; Watanabe Y; Kuroda Y; Kagami S
    Brain Dev; 2006 Mar; 28(2):99-103. PubMed ID: 16168596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not less likely than before that mean CSF HVA may be high in autism.
    Gillberg C
    Biol Psychiatry; 1993 Nov; 34(10):746-7. PubMed ID: 7507360
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.
    Engström G; Alling C; Blennow K; Regnéll G; Träskman-Bendz L
    Eur Neuropsychopharmacol; 1999 Sep; 9(5):399-405. PubMed ID: 10523046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history.
    Lindström LH
    Psychiatry Res; 1985 Apr; 14(4):265-73. PubMed ID: 2410940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood.
    Gillberg C; Svennerholm L
    Br J Psychiatry; 1987 Jul; 151():89-94. PubMed ID: 2445409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children.
    Winsberg BG; Sverd J; Castells S; Hurwic M; Perel JM
    Neuropediatrics; 1980 Aug; 11(3):250-5. PubMed ID: 6158716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Leckman JF; Cohen DJ; Shaywitz BA; Caparulo BK; Heninger GR; Bowers MB
    Arch Gen Psychiatry; 1980 Jun; 37(6):677-81. PubMed ID: 6155891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio.
    Risby ED; Hsiao JK; Sunderland T; Agren H; Rudorfer MV; Potter WZ
    Clin Pharmacol Ther; 1987 Nov; 42(5):547-54. PubMed ID: 2445515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine-serotonin relationship in clozapine response.
    Szymanski S; Lieberman J; Pollack S; Munne R; Safferman A; Kane J; Kronig M; Cooper T
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S85-9. PubMed ID: 7530378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF amine metabolites and depression.
    Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
    Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia.
    Assmann B; Köhler M; Hoffmann GF; Heales S; Surtees R
    Pediatr Res; 2002 Jul; 52(1):91-4. PubMed ID: 12084853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression.
    Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM
    Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H; Lindquist C; Sedvall G
    Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Shaywitz BA; Johnson WT; Bowers M
    Arch Gen Psychiatry; 1974 Dec; 31(6):845-53. PubMed ID: 4441252
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
    Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
    Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.